Monoclonal Antibodies to Yellow Fever E Protein

Applications:
This invention presents serious of monoclonal mouse IgG and IgM antibodies against yellow fever virus and dengue fever, and the antibody-producing hybridoma cell lines. These antibodies have multiple applications in production of vaccine against yellow fever.

Advantages:
These antibodies have been proved to be very helpful in testing, quality control, and manufacturing vaccines against yellow fever and dengue fever.  Antibodies available are for NS1 and E protein of dengue and yellow fever virus.

URV Reference Number: 6-1008A
Patent Information:
Category(s):
Research Tools
For Information, Contact:
Blaze Pharoah
Licensing Manager
University of Rochester
585-276-6600
blaze_pharoah@urmc.rochester.edu
Inventors:
Jacob Schlesinger
Keywords:
Antiviral
Therapy